Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | FDPS | P14324 | 7/20 | 0.34 |
| ▸ | CES1 | P23141 | 6/20 | 0.34 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3012391 | 0.92 | CES2 (0.45) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL23825028 | 0.90 | CES2 (0.48) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL1697655 | 0.90 | CES2 (0.48) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL23825086 | 0.90 | CES2 (0.48) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL3014254 | 0.84 | CES2 (0.34) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL23825120 | 0.83 | CES2 (0.41) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL23824935 | 0.83 | CES2 (0.37) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL1425867 | 0.82 | FDPS (0.36) | CES2LPAR1LPAR3FDPS | |
| SCHEMBL23825096 | 0.82 | CES2 (0.33) | CES2LPAR1LPAR3FAAHFDPS | |
| SCHEMBL19213219 | 0.82 | TSHR (0.40) | CES2LPAR1LPAR3FAAHFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119242156-A | High-toughness high-adhesion modified polyurethane building waterproof coating | 天津联鑫高高分子科技发展有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-114292582-B | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-113444439-B | Organic silicon-fluorine modified single-component polyurethane waterproof coating and preparation method thereof | 江苏苏博特新材料股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114292582-A | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-113444439-A | Organic silicon-fluorine modified single-component polyurethane waterproof coating and preparation method thereof | 江苏苏博特新材料股份有限公司 | 2021-09-28 | — | — | CN | claimed |
| CN-110452212-A | A kind of preparation method of 11- undecalactone class compound and caprolactone class compound | UNIV ZHEJIANG | 2019-11-15 | — | — | CN | claimed |
| EP-3882235-B1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND | UNIV KOBE NAT UNIV CORP (JP) | 2025-01-22 | — | — | EP | disclosed |
| CN-119242156-A | High-toughness high-adhesion modified polyurethane building waterproof coating | 天津联鑫高高分子科技发展有限公司 | 2025-01-03 | — | — | CN | disclosed |
| US-12060312-B2 | Production method for isocyanate compound | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2024-08-13 | — | — | US | disclosed |
| CN-114292582-B | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-113444439-B | Organic silicon-fluorine modified single-component polyurethane waterproof coating and preparation method thereof | 江苏苏博特新材料股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-114292582-A | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| WO-2022065133-A1 | METHOD FOR PRODUCING CARBONATE COMPOUND | 国立大学法人神戸大学 | 2022-03-31 | — | — | WO | disclosed |
| EP-2006283-A9 | PROCESS FOR PRODUCTION OF AMIDES OR LACTAMS | Daicel Chemical Industries, Ltd. (JP) | 2009-07-15 | — | — | EP | disclosed |
| US-20090093628-A1 | Process for Production of Amides or Lactams | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| EP-2006283-A2 | PROCESS FOR PRODUCTION OF AMIDES OR LACTAMS | Mainichi Intecio. (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-5424275-A | A 2-(pyrimidine-6yloxy or -6ylthio)-6-phenylbenzoic acids or a 2-dialkylaminooxycarbonyl-3-phenyl phenylthio or phenyloxy-pyrimidines antigrowth agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-06-13 | — | — | US | disclosed |
| US-5354729-A | Controlling weeds at low dosage; nonphytotoxic | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-10-11 | — | — | US | disclosed |
| EP-0593252-A1 | 2-substituted 6-phenyl-benzoic acid derivatives, their preparation and their use as herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-04-20 | — | — | EP | disclosed |
| EP-0579469-A2 | N-acyldihydroquinoline derivatives as herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093628-A1 | Process for Production of Amides or Lactams | AFF1, ADH1C, ADH1A | CES2 22/4885LPAR1 2742/4885LPAR3 3136/4885 |
| US-12060312-B2 | Production method for isocyanate compound | IDH2, CBR3, IDH3A | CES2 1339/4885LPAR1 3273/4885LPAR3 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.